Multidrug-resistant tuberculosis and the need for biosocial perspectives

International Journal of Tuberculosis and Lung Disease

Volumn 5, Issue 10, 2001, Pages 885-886

  Farmer, P ^a   Bayona, J ^a   Becerra, M ^a  

^a PARTNERS IN HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

COMORBIDITY; DIAGNOSTIC PROCEDURE; DRUG QUALITY; EDITORIAL; HEALTH CARE POLICY; HEALTH CARE QUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL PRACTICE; MEDICAL RESEARCH; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; RISK FACTOR; SOCIAL ASPECT; TREATMENT PLANNING; TUBERCULOSIS; TUBERCULOSIS CONTROL;

ANTIBIOTICS, ANTITUBERCULAR; DRUG RESISTANCE, MULTIPLE; HIV; HIV INFECTIONS; HUMANS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 0034780491     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (11)

1. The crisis in antibiotic resistance
2. Determinants of drug resistant tuberculosis: Analysis of 11 countries
3. Operational evaluation of treatment for tuberculosis: Results of a "standard" 12-month regimen in Peru
4. Transmission of tuberculosis to close contacts of patients with multidrugresistant tuberculosis
5. Standard short-course chemotherapy for drug-resistant tuberculosis: Treatment outcomes in 6 countries
6. Primary multidrug-resistant tuberculosis - Ivanovo Oblast, Russia, 1999
7. Inadequacy of the current WHO re-treatment regimen in a central Siberian prison: Treatment failure and MDRTB
8. Managerial successes, clinical failures
9. Classification of drug-resistant tuberculosis in an epidemic area
10. The dilemma of MDRTB in the global era